Pura Vida Investments’s STAAR Surgical STAA Stock Holding History

Pura Vida Investments’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-30,000	Closed	-$1.43M	–	59
2024 Q2	$1.43M	Buy	+30,000	New	+$1.31M	0.9%	33
2022 Q2	–	Sell	-85,000	Closed	-$6.79M	–	269
2022 Q1	$6.79M	Buy	+85,000	New	+$6.33M	0.22%	102
2019 Q4	–	Sell	-231,200	Closed	-$5.96M	–	119
2019 Q3	$5.96M	Buy	231,200 +25,000	+12%	+$760K	1.02%	38
2019 Q2	$6.06M	Buy	206,200 +150,000	+267%	+$4.33M	0.92%	37
2019 Q1	$1.92M	Buy	+56,200	New	+$1.99M	0.27%	78
2018 Q3	–	Sell	-17,500	Closed	-$543K	–	126
2018 Q2	$543K	Buy	+17,500	New	+$409K	0.22%	81
2015 Q2	–	Sell	-100,000	Closed	-$743K	–	81
2015 Q1	$743K	Buy	+100,000	New	+$731K	0.38%	52

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

RAM

Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pura Vida Investments's STAA Position: Q3 2024 in Review

Pura Vida Investments sold out of STAAR Surgical (STAA) in Q3 2024, closing a stake of 30,000 shares — an estimated $1.43M sold.

Pura Vida Investments first reported a position in STAA in Q2 2015 and held it in 21 quarters. The position peaked at $30.3M in Q1 2021. 236 funds tracked by Wall St. Rank hold STAA as of Q3 2024.

Pura Vida Investments reported no remaining STAAR Surgical position as of Q3 2024 after selling out during the quarter.
Pura Vida Investments sold 30,000 STAAR Surgical shares in Q3 2024, an estimated $1.43M.
Pura Vida Investments first reported a position in STAAR Surgical in Q2 2015 and held it in 21 quarters.
Pura Vida Investments's STAAR Surgical position peaked at $30.3M in Q1 2021.
236 funds tracked by Wall St. Rank held STAAR Surgical as of Q3 2024.

Based on Pura Vida Investments's 13F filing for Q3 2024, filed 14 Nov 2024.